Regulation of astrocyte lipid metabolism and ApoE secretion by the microglial oxysterol, 25-hydroxycholesterol
2023/02/25 by Anil G. Cashikar, Danira Toral-Ríos, Danira Toral-Rios +9 · 27 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Cholesterol and Lipid Metabolism #Sphingolipid Metabolism and Signaling #Peroxisome Proliferator-Activated Receptors
paper · pdf · doi:10.1016/j.jlr.2023.100350
Abstract
Neuroinflammation, a major hallmark of Alzheimer's disease and several other neurological and psychiatric disorders, is often associated with dysregulated cholesterol metabolism. Relative to homeostatic microglia, activated microglia express higher levels of Ch25h, an enzyme that hydroxylates cholesterol to produce 25-hydroxycholesterol (25HC). 25HC is an oxysterol with interesting immune roles stemming from its ability to regulate cholesterol metabolism. Since astrocytes synthesize cholesterol in the brain and transport it to other cells via ApoE-containing lipoproteins, we hypothesized that secreted 25HC from microglia may influence lipid metabolism as well as extracellular ApoE derived from astrocytes. Here, we show that astrocytes take up externally added 25HC and respond with altered lipid metabolism. Extracellular levels of ApoE lipoprotein particles increased after treatment of astrocytes with 25HC without an increase in Apoe mRNA expression. In mouse astrocytes-expressing human ApoE3 or ApoE4, 25HC promoted extracellular ApoE3 better than ApoE4. Increased extracellular ApoE was due to elevated efflux from increased Abca1 expression via LXRs as well as decreased lipoprotein reuptake from suppressed Ldlr expression via inhibition of SREBP. 25HC also suppressed expression of Srebf2, but not Srebf1, leading to reduced cholesterol synthesis in astrocytes without affecting fatty acid levels. We further show that 25HC promoted the activity of sterol-o-acyl transferase that led to a doubling of the amount of cholesteryl esters and their concomitant storage in lipid droplets. Our results demonstrate an important role for 25HC in regulating astrocyte lipid metabolism.
Cited by
- 25-Hydroxycholesterol in health and diseases
- The role of 25-hydroxycholesterol in the pathophysiology of brain vessel dysfunction associated with infection and cholesterol dysregulation
- Oxygen-induced pathological angiogenesis promotes intense lipid synthesis and remodeling in the retina. [europepmc]
- Cell type-specific roles of APOE4 in Alzheimer disease. [europepmc]
- Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy. [europepmc]
- Inflammatory, metabolic, and sex-dependent gene-regulatory dynamics of microglia and macrophages in neonatal hippocampus after hypoxia-ischemia. [europepmc]
- Gut microbiota-host lipid crosstalk in Alzheimer's disease: implications for disease progression and therapeutics. [europepmc]
- Astrocytic HILPDA promotes lipid droplets generation to drive cognitive dysfunction in mice with sepsis-associated encephalopathy. [europepmc]
- Research progress of SREBP and its role in the pathogenesis of autoimmune rheumatic diseases. [europepmc]
- 25-hydroxycholesterol promotes brain cytokine production and leukocyte infiltration in a mouse model of lipopolysaccharide-induced neuroinflammation. [europepmc]
- Inhibiting the Cholesterol Storage Enzyme ACAT1/SOAT1 in Myelin Debris-Treated Microglial Cell Lines Activates the Gene Expression of Cholesterol Efflux Transporter ABCA1. [europepmc]
- Alzheimer's Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models). [europepmc]
- Fundamental Neurochemistry Review: Lipids across microglial states. [europepmc]
- Lipid droplets in central nervous system and functional profiles of brain cells containing lipid droplets in various diseases. [europepmc]
- Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications. [europepmc]
- Astrocyte-secreted cues promote neural maturation and augment activity in human forebrain organoids. [europepmc]
- The role of 25-hydroxycholesterol in the pathophysiology of brain vessel dysfunction associated with infection and cholesterol dysregulation. [europepmc]
- Lipid and lipoprotein metabolism in microglia: Alzheimer's disease mechanisms and interventions. [europepmc]
- Microglial lipid droplets as therapeutic targets in age-related neurodegenerative diseases. [europepmc]
- Microglia-derived APOE2 improves remyelination even in the presence of endogenous APOE4. [europepmc]
- A Lipid Road to Neuroimmunology: Fatty Acids Linking Immune and Nervous Systems. [europepmc]
- APOE Lipoprotein Particles: Pathophysiology, Therapy, and the Crosstalk in Alzheimer's Disease and Cardiovascular Disease. [europepmc]
- Structure-activity relationships of steroid and sterol neuromodulators on inflammatory markers in a murine microglial cell line. [europepmc]
- ApoE expression across the CNS: Who, What, Where, When, and How (much)? [europepmc]
- Targeting Brain Cholesterol Homeostasis in Alzheimer's Disease: Mechanisms and Therapeutic Perspectives. [europepmc]
- From Metabolism to Mind: The Cardio–Metabolic–Brain Axis and the Role of Insulin Resistance—A Review [europepmc]
- Ch25h/25HC axis orchestrates phagocytosis and lipid metabolism after intracerebral haemorrhage [europepmc]
Related